These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 11446565

  • 1. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.
    Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Ordi J, Rimola A, Rodés J, Muñoz-Gómez J.
    Osteoporos Int; 2001; 12(6):484-92. PubMed ID: 11446565
    [Abstract] [Full Text] [Related]

  • 2. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J.
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
    Thiébaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P.
    Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P, Kent GN, Adler BD, Matz L, Watson I, O'Driscoll GJ, Hurley DM.
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A.
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [Abstract] [Full Text] [Related]

  • 8. Bone loss and turnover after cardiac transplantation.
    Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, Mancini D, Michler RE, Aaronson K, Addesso V, Lo SH.
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [Abstract] [Full Text] [Related]

  • 9. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL.
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [Abstract] [Full Text] [Related]

  • 11. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [Abstract] [Full Text] [Related]

  • 12. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, Obermayer-Pietsch B, Leb G, Dobnig H.
    Wien Klin Wochenschr; 2002 Aug 30; 114(15-16):717-24. PubMed ID: 12602117
    [Abstract] [Full Text] [Related]

  • 13. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
    Fassbender WJ, Balli M, Görtz B, Hinrichs B, Kaiser HE, Tracke HS.
    In Vivo; 2000 Aug 30; 14(5):611-8. PubMed ID: 11125545
    [Abstract] [Full Text] [Related]

  • 14. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T, Campbell J, Bryant C, Lynch W.
    Cancer; 1998 Oct 15; 83(8):1561-6. PubMed ID: 9781950
    [Abstract] [Full Text] [Related]

  • 15. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul 15; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ.
    J Bone Miner Res; 1999 Dec 15; 14(12):2150-8. PubMed ID: 10620075
    [Abstract] [Full Text] [Related]

  • 17. The heterogeneity of bone disease in cirrhosis: a multivariate analysis.
    Crawford BA, Kam C, Donaghy AJ, McCaughan GW.
    Osteoporos Int; 2003 Dec 15; 14(12):987-94. PubMed ID: 14504696
    [Abstract] [Full Text] [Related]

  • 18. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
    Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martínez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J.
    Calcif Tissue Int; 2001 Feb 15; 68(2):83-6. PubMed ID: 11310351
    [Abstract] [Full Text] [Related]

  • 19. Predictors of bone mass in healthy older men in the community.
    Smerdely P, Seller M, Smith A, Day P, Diamond T.
    Med J Aust; 2000 Aug 21; 173(4):183-6. PubMed ID: 11008590
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S, Ghods FJ.
    Iran J Kidney Dis; 2012 Jul 21; 6(4):295-9. PubMed ID: 22797100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.